These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 27227913

  • 1. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH.
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 3. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H, Ooi M, Yu Z, Wang Q, Li Z, Lu Q, Wu Y.
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [Abstract] [Full Text] [Related]

  • 4. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y, Zheng Z, Xu R, Zhang H, Yin J, Liu X, Zhang J, Chen G, Zhang Z.
    Medicine (Baltimore); 2024 Mar 01; 103(9):e37289. PubMed ID: 38428860
    [Abstract] [Full Text] [Related]

  • 5. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

  • 6. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
    Lin JX, Wu D, Jiang YM, Chen JY, Lin GT, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Zheng CH, Huang CM.
    Zhonghua Wai Ke Za Zhi; 2022 Sep 01; 60(9):853-859. PubMed ID: 36058712
    [Abstract] [Full Text] [Related]

  • 7. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D, Cao S, Tan X, Liu S, Liu X, Niu Z, Chen D, Wang D, Zhang J, Lv L, Li Y, Jiang H, Guo D, Li Y, Li Z, Zhou Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):156-163. PubMed ID: 30799538
    [Abstract] [Full Text] [Related]

  • 8. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
    Qi X, Liu M, Xu K, Tan F, Gao P, Yao Z, Zhang N, Yang H, Zhang C, Xing J, Cui M, Su X.
    Surg Endosc; 2024 Jul 25; 38(7):3828-3837. PubMed ID: 38822144
    [Abstract] [Full Text] [Related]

  • 10. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec 25; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 11. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X, Li Z, Tan C, Ye X, Xiong J, Liu J, Mo A, Shi Y, Qian F, Yu P, Zhao Y.
    Front Oncol; 2021 Dec 25; 11():748694. PubMed ID: 34926257
    [Abstract] [Full Text] [Related]

  • 12. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M.
    Gastric Cancer; 2013 Oct 25; 16(4):590-5. PubMed ID: 23179369
    [Abstract] [Full Text] [Related]

  • 13. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
    Chen L, Tang K, Wang S, Chen D, Ding K.
    Cancer Control; 2021 Oct 25; 28():10732748211026668. PubMed ID: 34155922
    [Abstract] [Full Text] [Related]

  • 14. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
    Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q, Wei SJ.
    World J Gastroenterol; 2015 Sep 14; 21(34):9999-10007. PubMed ID: 26379405
    [Abstract] [Full Text] [Related]

  • 15. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C, Zhu HT, Xu ZY, Yu JF, Du YA, Huang L, Yu PF, Wang LJ, Cheng XD.
    J Int Med Res; 2019 Jan 14; 47(1):398-410. PubMed ID: 30296865
    [Abstract] [Full Text] [Related]

  • 16. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S, Kurokawa Y, Takeuchi H, Kishi K, Ito Y, Ohi M, Matsuda T, Hamakawa T, Hasegawa S, Yoshikawa T, Hiki N.
    Eur J Surg Oncol; 2015 Oct 14; 41(10):1348-53. PubMed ID: 26087995
    [Abstract] [Full Text] [Related]

  • 17. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM, Lv CB, Lin JX, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Cao LL, Lin M, Tu RH.
    Surg Endosc; 2017 Sep 14; 31(9):3495-3503. PubMed ID: 27981384
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 19. Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study.
    Li J, Xiong W, Ou H, Yang T, Jiang S, Huang H, Zheng Y, Luo L, Peng X, Wang W.
    Surg Endosc; 2024 Apr 25; 38(4):1986-1994. PubMed ID: 38381159
    [Abstract] [Full Text] [Related]

  • 20. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL.
    Ann Thorac Surg; 2019 Sep 25; 108(3):845-851. PubMed ID: 31102632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.